Page last updated: 2024-09-03

3-n-(2-fluoroethyl)spiperone and Schizophrenia

3-n-(2-fluoroethyl)spiperone has been researched along with Schizophrenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bravi, D; Cavallaro, R; Colombo, C; Fazio, F; Galli, L; Gobbo, C; Lucignani, G; Messa, C; Moresco, RM; Rizzo, G; Smeraldi, E; VelonĂ , I1
Coenen, HH; Heiss, WD; Jovkar, S; Laufer, P; Pawlik, G; Rudolf, J; Stöcklin, G; Wienhard, K1

Trials

1 trial(s) available for 3-n-(2-fluoroethyl)spiperone and Schizophrenia

ArticleYear
Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine.
    Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:3

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Double-Blind Method; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Prospective Studies; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Spiperone

2004

Other Studies

1 other study(ies) available for 3-n-(2-fluoroethyl)spiperone and Schizophrenia

ArticleYear
PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic system.
    Journal of neural transmission. General section, 1990, Volume: 81, Issue:3

    Topics: Adolescent; Adult; Aged; Brain; Caudate Nucleus; Female; Humans; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Spiperone; Tomography, Emission-Computed

1990